Pathogen Detection

News Pathogen Detection

• QIAGEN acquires additional PCR licenses from Roche and Idaho Technology

  QIAGEN announced that it has acquired additional licenses from Roche and Idaho Technology related to the use of instrumentation and reagents for PCR-based molecular testing. Financial details were not disclosed. The agreements cover thermal cycler rights and real-time polymerase chain reaction (PC more

• Seegene and Shimadzu Agree to Join Multi-Pathogen Tests and Platform for Combined Analytics Solution

  Seegene, Inc. and Shimadzu Corporation announced a strategic partnership to combine Seegene's Seeplex(R) multi-pathogen tests with Shimadzu's MultiNA (1) analytical platform. Under terms of the deal, Shimadzu and Seegene will collaborate on integrating the Seeplex polymerase chain reaction-based tes more

• U.S. Department Of Defense selects Applied Biosystems for development of instrument system to identify infectious diseases

  Applied Biosystems, an Applera Corporation business, announced that the U.S. Department of Defense has awarded the company a $24.5 million contract to accelerate the development of a prototype instrument system that is intended to improve the way infectious diseases are identified for epidemiologica more

White papers Pathogen Detection

• LOOXSTER® concentrates bacterial DNA
  

  Detection of the bacterial content of a specific sample, irrelevant from its source, is not as straightforward as it seems. In clinical microbiology laboratories, the gold standard method for the detection of pathogens in patients suspected of systemic infections is the blood culture. However, this technique is known to have many drawbacks especially with regard to patient's antibiotics treatment, low abundance and non-cultivable organisms. Moreover, it takes usually 3 to 5 days to obtain a result from blood culture which is too late to initiate proper antibiotic therapy. Amplification-based methods such as PCR allow results in a more rapid fashion. However, their sensitivity, to date, are no better, and sometimes worse, than culture-based methods. more

• Looxster® - Enrichment and isolation of bacterial DNA using Pureprove® Technology
  

  Detection of the bacterial content of a specific sample, irrelevant from its source (i.e. Clinical, Food or Environmental), is not as straightforward as it seems. In clinical microbiology laboratories, the gold standard method for the detection of pathogens in patients suspected of systemic infections is the blood culture. However, this technique is known to have many drawbacks especially with regard to non-cultivable organisms, low abundance (longer lag phase) and patient's antibiotics treatment. more

Websites Pathogen Detection